Table 4.
BP in H-CRIC/Hispanic CRIC Participants compared to Non-Hispanic White and Black CRIC Participants1
| P | ||||||
|---|---|---|---|---|---|---|
| Variable |
Hispanic (n=497) |
Non-Hispanic White (n=1638) |
Non-Hispanic Black (n=1650) |
Hispani c vs. White |
Hispanic vs. Black |
|
| eGFR Strata | ||||||
| eGFR<30 (n=702) | - | - | ||||
| SBP (mmHg) | 142.3 +/−23.0 | 123.4 +/−20.4 | 135.0 +/−25.1 | <0.001 | 0.004 | |
| DBP (mmHg) | 73.1 +/−12.7 | 66.4 +/−12.0 | 71.6 +/−14.0 | <0.001 | 0.3 | |
| MAP (mmHg) | 96.2 +/−14.1 | 85.4 +/−12.7 | 92.7 +/−15.3 | <0.001 | 0.03 | |
| BP>130/80 mmHg | 98 (73%) | 84 (35%) | 191 (60%) | <0.001 | 0.006 | |
| eGFR 30–<45 (n=1382) | - | - | ||||
| SBP (mmHg) | 137.1 +/−24.3 | 123.8 +/−19.1 | 134.7 +/−23.8 | <0.001 | 0.2 | |
| DBP (mmHg) | 72.0 +/−12.9 | 68.1 +/−11.1 | 73.1 +/−13.7 | <0.001 | 0.4 | |
| MAP (mmHg) | 93.7 +/−14.5 | 86.6 +/−11.6 | 93.7 +/−15.1 | <0.001 | 0.9 | |
| BP>130/80 mmHg | 126 (62%) | 216 (38%) | 349 (58%) | <0.001 | 0.3 | |
| eGFR 45–<60 (n=1141) | - | - | ||||
| SBP (mmHg) | 130.8 +/−22.9 | 121.6 +/−18.4 | 131.7 +/−21.0 | <0.001 | 0.7 | |
| DBP (mmHg) | 72.1 +/−13.3 | 70.2 +/−11.4 | 74.0 +/−13.2 | 0.1 | 0.2 | |
| MAP (mmHg) | 91.7 +/−14.4 | 87.4 +/−12.0 | 93.2 +/−13.6 | <0.001 | 0.3 | |
| BP>130/80 mmHg | 62 (55%) | 192 (36%) | 291 (59%) | <0.001 | 0.4 | |
| eGFR >= 60 (n=560) | ||||||
| SBP (mmHg) | 125.5 +/−18.8 | 116.9 +/−15.4 | 127.8 +/−22.0 | 0.001 | 0.5 | |
| DBP (mmHg) | 74.7 +/−11.4 | 70.6 +/−11.1 | 78.2 +/−14.2 | 0.02 | 0.1 | |
| MAP (mmHg) | 91.6 +/−12.9 | 86.0 +/−10.9 | 94.8 +/−15.5 | 0.002 | 0.2 | |
| BP>130/80 mmHg | 21 (49%) | 81 (28%) | 111 (50%) | 0.005 | 0.9 | |
| Albuminuria Strata | ||||||
| UACR <30 (n=1564) | - | - | ||||
| SBP (mmHg) | 122.0 +/−20.6 | 118.0 +/−16.3 | 124.1 +/−19.4 | 0.02 | 0.3 | |
| DBP (mmHg) | 67.3 +/−12.1 | 67.8 +/−10.7 | 70.7 +/−12.5 | 0.7 | 0.009 | |
| MAP (mmHg) | 85.5 +/−13.2 | 84.5 +/−10.7 | 88.5 +/−13.0 | 0.3 | 0.03 | |
| BP>130/80 mmHg | 44 (38%) | 228 (27%) | 255 (42%) | 0.01 | 0.5 | |
| UACR 30–<300 (n=955) | - | - | ||||
| SBP (mmHg) | 133.2 +/−20.0 | 122.9 +/−18.5 | 132.6 +/−22.2 | <0.001 | 0.8 | |
| DBP (mmHg) | 69.6 +/−11.9 | 68.3 +/−11.4 | 73.6 +/−14.0 | 0.3 | 0.01 | |
| MAP (mmHg) | 90.8 +/−12.6 | 86.5 +/−11.6 | 93.2 +/−14.6 | 0.001 | 0.1 | |
| BP>130/80 mmHg | 51 (54%) | 148 (36%) | 247 (56%) | 0.001 | 0.7 | |
| UACR >=300 (n=1110) | - | - | ||||
| SBP (mmHg) | 143.2 +/−22.9 | 129.8 +/−21.2 | 143.2 +/−23.1 | <0.001 | 0.9 | |
| DBP (mmHg) | 76.0 +/−12.3 | 72.5 +/−12.2 | 77.2 +/−13.9 | <0.001 | 0.3 | |
| MAP (mmHg) | 98.4 +/−13.1 | 91.6 +/−12.9 | 99.2 +/−14.2 | <0.001 | 0.5 | |
| BP>130/80 mmHg | 186 (76%) | 183 (53%) | 395 (76%) | <0.001 | 0.8 | |
1
continous variables are represented by mean +/− standard deviation; categorical variables are given as frequency (percentage)
eGFR given in mL/min/1.73 m2
UACR, urine albumin-creatinine ratio; eGFR, estimated glomerular filtration rate; CRIC, Chronic Renal Insufficiency Cohort; H-CRIC, Hispanic Chronic Renal Insufficiency Cohort; BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; MAP, mean arterial pressure;